Emerging Role of Fibroblast Growth Factor Receptor 2b (FGFR2b) Inhibitors in Gastroesophageal Cancers

Faculty: Tanios S. Bekaii-Saab, MD
Disclosures

Faculty

Tanios S. Bekaii-Saab, MD
David F. and Margaret T. Grohne Professsor of Novel Therapeutics for Cancer Research
Chair and Consultant, Division of Hematology and Medical Oncology
Professor, Mayo Clinic College of Medicine and Science
Mayo Clinic in Arizona

Discover more from OmniOncology.net

Subscribe now to keep reading and get access to the full archive.

Continue reading